This Article Full Text Full Text (PDF) All Versions of this Article: 40/8/2754    most recent STROKEAHA.109.554790v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Google Scholar Articles by Kersbergen, K. J. Articles by Groenendaal, F. PubMed PubMed Citation Articles by Kersbergen, K. J. Articles by Groenendaal, F. Pubmed/NCBI databases Medline Plus Health Information Blood Thinners Related Collections Heparin Cerebral Venous Thrombosis Computerized tomography and Magnetic Resonance Imaging Stroke in Children and the Young Anticoagulants

(Stroke. 2009;40:2754.)
© 2009 American Heart Association, Inc.

Original Contributions

Anticoagulation Therapy and Imaging in Neonates With a Unilateral Thalamic Hemorrhage Due to Cerebral Sinovenous Thrombosis

Karina J. Kersbergen, BM; Linda S. de Vries, MD, PhD; H. L.M.(Irma) van Straaten, MD, PhD; Manon J.N.L. Benders, MD, PhD; Rutger A.J. Nievelstein, MD, PhD Floris Groenendaal, MD, PhD

From the Department of Neonatology (K.J.K., L.S.d.V., M.J.N.L.B., F.G.), Wilhelmina Children’s Hospital, University Medical Center, Utrecht, The Netherlands; the Department of Radiology (R.A.J.N.), University Medical Center, Utrecht, The Netherlands; and the Department of Neonatology (H.L.M.v.S.), Isala Clinics, Zwolle, The Netherlands.

Correspondence to Linda S. de Vries, MD, PhD, Department of Neonatology, KE 04.123.1, University Medical Center Utrecht/Wilhelmina Children’s Hospital, Lundlaan 6, 3584 EA Utrecht, The Netherlands. E-mail l.s.devries{at}umcutrecht.nl

Background and Purpose— Cerebral sinovenous thrombosis is a rare disorder with a high risk of an adverse neurodevelopmental outcome. Until now, anticoagulation therapy has been restricted to neonates without an associated parenchymal hemorrhage. In this study, we describe sequential neuroimaging findings and use of anticoagulation therapy in newborn infants with a unilateral thalamic hemorrhage due to cerebral sinovenous thrombosis.

Methods— Ten neonates with a unilateral thalamic hemorrhage and cerebral sinovenous thrombosis were studied. Diagnosis was suspected using cranial ultrasound and confirmed with MRI/MR venography. Eight infants had a repeat MRI at 3 to 7 months. Neurodevelopmental outcome was assessed from 3 months until 5 years.

Results— One infant died. Seven infants were treated with low-molecular-weight heparin. No side affects were noted. MRI showed involvement of multiple sinuses, additional intraventricular hemorrhage, and white matter lesions in all infants. Recanalization was present on the repeat MRI at 3 months in all infants. Treatment was delayed in one infant and anticoagulation was started only after extension of the thalamic hemorrhage. He required a ventriculoperitoneal drain for posthemorrhagic ventricular dilatation and developed cerebral visual impairment and global delay. Two other infants showed global delay and one of them also developed postneonatal epilepsy. Mild asymmetry in tone was present in 4 children.

Conclusions— Cerebral sinovenous thrombosis was found in 10 neonates with unilateral thalamic hemorrhage. Diagnosis was suspected on cranial ultrasound and confirmed with MRI/MR venography. Treatment with low-molecular-weight heparin in newborn infants with a thalamic hemorrhage due to cerebral sinovenous thrombosis appears to be safe and should be considered. Long-term follow-up will be needed to assess cognitive outcome.

Key Words: anticoagulation • neuroradiology • pediatric stroke • venous thrombosis